IBDEI2QN ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45951,1,4,0)
 ;;=4^R60.9
 ;;^UTILITY(U,$J,358.3,45951,2)
 ;;=^5019534
 ;;^UTILITY(U,$J,358.3,45952,0)
 ;;=I96.^^203^2267^4
 ;;^UTILITY(U,$J,358.3,45952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45952,1,3,0)
 ;;=3^Gangrene NEC
 ;;^UTILITY(U,$J,358.3,45952,1,4,0)
 ;;=4^I96.
 ;;^UTILITY(U,$J,358.3,45952,2)
 ;;=^5008081
 ;;^UTILITY(U,$J,358.3,45953,0)
 ;;=E10.9^^203^2268^5
 ;;^UTILITY(U,$J,358.3,45953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45953,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,45953,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,45953,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,45954,0)
 ;;=E11.40^^203^2268^7
 ;;^UTILITY(U,$J,358.3,45954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45954,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy Manifestations
 ;;^UTILITY(U,$J,358.3,45954,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,45954,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,45955,0)
 ;;=E10.40^^203^2268^2
 ;;^UTILITY(U,$J,358.3,45955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45955,1,3,0)
 ;;=3^DM Type 1 w/ Neuropathy Manifestations
 ;;^UTILITY(U,$J,358.3,45955,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,45955,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,45956,0)
 ;;=E11.51^^203^2268^9
 ;;^UTILITY(U,$J,358.3,45956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45956,1,3,0)
 ;;=3^DM Type 2 w/ Peripheral Circulatory Disease
 ;;^UTILITY(U,$J,358.3,45956,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,45956,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,45957,0)
 ;;=E10.51^^203^2268^4
 ;;^UTILITY(U,$J,358.3,45957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45957,1,3,0)
 ;;=3^DM Type 1 w/ Peripheral Circulatory Disease
 ;;^UTILITY(U,$J,358.3,45957,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,45957,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,45958,0)
 ;;=E11.621^^203^2268^6
 ;;^UTILITY(U,$J,358.3,45958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45958,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,45958,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,45958,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,45959,0)
 ;;=E10.621^^203^2268^1
 ;;^UTILITY(U,$J,358.3,45959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45959,1,3,0)
 ;;=3^DM Type 1 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,45959,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,45959,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,45960,0)
 ;;=E11.51^^203^2268^8
 ;;^UTILITY(U,$J,358.3,45960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45960,1,3,0)
 ;;=3^DM Type 2 w/ Peripheral Angiopathy
 ;;^UTILITY(U,$J,358.3,45960,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,45960,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,45961,0)
 ;;=E10.51^^203^2268^3
 ;;^UTILITY(U,$J,358.3,45961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45961,1,3,0)
 ;;=3^DM Type 1 w/ Peripheral Angiopathy
 ;;^UTILITY(U,$J,358.3,45961,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,45961,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,45962,0)
 ;;=S43.001S^^203^2269^20
 ;;^UTILITY(U,$J,358.3,45962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45962,1,3,0)
 ;;=3^Subluxation,Right Shoulder,Sequela
 ;;^UTILITY(U,$J,358.3,45962,1,4,0)
 ;;=4^S43.001S
 ;;^UTILITY(U,$J,358.3,45962,2)
 ;;=^5027659
 ;;^UTILITY(U,$J,358.3,45963,0)
 ;;=S43.002S^^203^2269^16
 ;;^UTILITY(U,$J,358.3,45963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45963,1,3,0)
 ;;=3^Subluxation,Left Shoulder,Sequela
 ;;^UTILITY(U,$J,358.3,45963,1,4,0)
 ;;=4^S43.002S
 ;;^UTILITY(U,$J,358.3,45963,2)
 ;;=^5027662
 ;;^UTILITY(U,$J,358.3,45964,0)
 ;;=S43.004S^^203^2269^12
 ;;^UTILITY(U,$J,358.3,45964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45964,1,3,0)
 ;;=3^Dislocation,Right Shoulder,Sequela
